RAD51 and breast carcinoma: Although this mutation did not have any effect on RAD51-interacting activity, the reported HCR mutation, A1108G from canine mammary tumors, increased the RAD51-interacting activity, and the two HCR mutations derived from human breast cancer, S1114P and T1115P, reduced the RAD51-interacting activity of BRC repeats.